For more than 2 decades, the most hotly contested surgical debate in the management of thyroid cancer was the extent of surgery: total vs near-total thyroidectomy vs unilateral lobectomy.
1,2 Superseding this controversy since the turn of the 21st century has emerged the question of extent of associated lymph node dissection, particularly in papillary thyroid cancer (PTC), which represents nearly 90% of all thyroid cancers.